Slit/Robo pathway: A promising therapeutic target for cancer

Drug Discovery Today

Volumn 20, Issue 1, 2015, Pages 156-164

  Gara, Rishi K ^a   Kumari, Sonam ^a   Ganju, Aditya ^a   Yallapu, Murali M ^a   Jaggi, Meena ^a   Chauhan, Subhash C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOCORTICOID RECEPTOR; HISTONE DEACETYLASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALMITIC ACID; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; ROUNDABOUT RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEMAPHORIN; SLIT PROTEIN; THAPSIGARGIN; VASCULOTROPIN RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN RECEPTOR; NERVE PROTEIN; SLIT PROTEIN, VERTEBRATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIVISION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; COLORECTAL CANCER; DRUG TARGETING; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GLIOBLASTOMA; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; METASTASIS; NONHODGKIN LYMPHOMA; NONHUMAN; ONCOGENE C MYC; OVARY CANCER; PANCREAS CANCER; PHYSIOLOGICAL PROCESS; PROSTATE CANCER; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STOMACH CANCER; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER; ANIMAL; CHEMISTRY; METABOLISM; NEOPLASM; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ANIMALS; GLYCOPROTEINS; HUMANS; NEOPLASMS; NERVE TISSUE PROTEINS; PROTEIN CONFORMATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84921499227     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.09.008     Document Type: Review

References (95)

1. Andrews, W. et al. (2006) Robo1 regulates the development of major axon tracts and interneuron migration in the forebrain. Development 133, 2243-2252
2. Dickinson, R.E. and Duncan, W.C. (2010) The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction 139, 697-704
3. Refai, O. et al. (2013) Extension of the Caenorhabditis elegans pharyngeal M1 neuron axon is regulated by multiple mechanisms. G3 (Bethesda) 3, 2015-2029
4. Brose, K. et al. (1999) Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 96, 795-806
5. Rothberg, J.M. et al. (1988) Slit: an EGF-homologous locus of D. melanogaster involved in the development of the embryonic central nervous system. Cell 55, 1047-1059
6. Kidd, T. et al. (1998) Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 92, 205-215
7. Seeger, M. et al. (1993) Mutations affecting growth cone guidance in Drosophila: genes necessary for guidance toward or away from the midline. Neuron 10, 409-426
8. Nguyen-Ba-Charvet, K.T. and Chedotal, A. (2002) Role of Slit proteins in the vertebrate brain. J. Physiol. 96, 91-98
9. Dickinson, R.E. et al. (2004) Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br. J. Cancer 91, 2071-2078
10. Fujiwara, M. et al. (2006) Potential role of the Slit/Robo signal pathway in angiogenesis. Vasc. Med. 11, 115-121
11. Rothberg, J.M. and Artavanis-Tsakonas, S. (1992) Modularity of the slit protein. Characterization of a conserved carboxy-terminal sequence in secreted proteins and a motif implicated in extracellular protein interactions. J. Mol. Biol. 227, 367-370
12. Rothberg, J.M. et al. (1990) Slit: an extracellular protein necessary for development of midline glia and commissural axon pathways contains both EGF and LRR domains. Genes Dev. 4, 2169-2187
13. Domyan, E.T. et al. (2013) Roundabout receptors are critical for foregut separation from the body wall. Dev. Cell 24, 52-63
14. Sundaresan, V. et al. (1995) Somatic genetic changes in lung cancer and precancerous lesions. Ann. Oncol. 6 (Suppl. 1), 27-31
15. Zabarovsky, E.R. et al. (2002) Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21, 6915-6935
16. Chang, P.H. et al. (2012) Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/beta-catenin pathway. Cancer Res. 72, 4652-4661
17. Mertsch, S. et al. (2008) Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J. Neurooncol. 87, 1-7
18. Shibue, T. and Weinberg, R.A. (2011) Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin. Cancer Biol. 21, 99-106
19. Chang, J. and Erler, J. (2014) Hypoxia-mediated metastasis. Adv. Exp. Med. Biol. 772, 55-81
20. Bailey, K.M. et al. (2012) Targeting the metabolic microenvironment of tumors. Adv. Pharmacol. 65, 63-107
21. Tang, H. et al. (2014) Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis 35, 1039-1045
22. Biankin, A.V. et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405
23. Stein, E. and Tessier-Lavigne, M. (2001) Hierarchical organization of guidance receptors: silencing of netrin attraction by slit through a Robo/DCC receptor complex. Science 291, 1928-1938
24. Paradisi, A. et al. (2009) Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc. Natl. Acad. Sci. U. S. A. 106, 17146-17151
25. Castets, M. et al. (2012) DCC constrains tumour progression via its dependence receptor activity. Nature 482, 534-537
26. Dai, C.F. et al. (2011) Expression and roles of Slit/Robo in human ovarian cancer. Histochem. Cell Biol. 135, 475-485
27. Schmid, B.C. et al. (2007) The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells. Breast Cancer Res. Treat. 106, 333-342
28. Latil, A. et al. (2003) Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int. J. Cancer 103, 306-315
29. Prasad, A. et al. (2004) Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J. Biol. Chem. 279, 9115-9124
30. Stella, M.C. et al. (2009) The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. Mol. Biol. Cell 20, 642-657
31. Wick, M.J. et al. (2005) Lung Kruppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter. Biochem. J. 387, 239-246
32. Ueoka, Y. et al. (2000) Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br. J. Cancer 82, 891-899
33. Robinson, K.W. and Sandler, A.B. (2013) The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agents. Oncologist 18, 115-122
34. Denk, A.E. et al. (2011) Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. Int. J. Mol. Med. 28, 721-726
35. Lahoz, A. and Hall, A. (2013) A tumor suppressor role for srGAP3 in mammary epithelial cells. Oncogene 32, 4854-4860
36. Dallol, A. et al. (2003) Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 22, 4611-4616
37. Dallol, A. et al. (2002) SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res. 62, 5874-5880
38. Legg, J.A. et al. (2008) Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis 11, 13-21
39. Wang, L.J. et al. (2008) Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci. 99, 510-517
40. Mehlen, P. et al. (2011) Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat. Rev. Cancer 11, 188-197
41. Nasarre, P. et al. (2010) Guidance molecules in lung cancer. Cell Adhes. Migr. 4, 130-145
42. Bauer, K. et al. (2011) Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line. Carcinogenesis 32, 935-943
43. Marlow, R. et al. (2008) SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res. 68, 7819-7827
44. Wu, J.Y. et al. (2001) The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 410, 948-952
45. Wyler, L. et al. (2014) Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br. J. Cancer 110, 686-694
46. Fang, W. et al. (2014) Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Carcinogenesis 35, 1780-1787
47. Mohamed, M.M. et al. (2014) Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. Int. J. Biochem. Cell Biol. 46, 138-147
48. Xuan, Q.J. et al. (2014) Tumor-associated macrophages are correlated with tamoxifen resistance in the postmenopausal breast cancer patients. Pathol. Oncol. Res. 20, 619-624
49. Yang, Q. et al. (2014) Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer. Br. J. Cancer 110, 1288-1297
50. Leek, R.D. et al. (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer 79, 991-995
51. Mirakaj, V. et al. (2011) Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proc. Natl. Acad. Sci. U. S. A. 108, 6555-6560
52. Gohrig, A. et al. (2014) Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. Cancer Res. 74, 1529-1540
53. Kim, H.K. et al. (2008) Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. Neoplasia 10, 1411-1420
54. Dunwell, T.L. et al. (2009) Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics 4, 265-269
55. Kanellis, J. et al. (2004) Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis. Am. J. Pathol. 165, 341-352
56. Jeon, E.S. et al. (2010) Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells. Exp. Mol. Med. 42, 280-293
57. Ratajczak, M.Z. et al. (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20, 1915-1924
58. Xue, B. et al. (2013) Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by alphavbeta6 integrin-mediated signaling in ovarian cancer. Mol. Cell. Biochem. 380, 177-184
59. Sobolik, T. et al. (2014) CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways. Mol. Biol. Cell 25, 566-582
60. Hoellenriegel, J. et al. (2014) The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization. Blood 123, 1032-1039
61. Wang, B. et al. (2014) SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin alphavbeta6. Carcinogenesis 35, 282-291
62. Choi, Y.H. et al. (2014) CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells. Mol. Cancer Res. 12, 38-47
63. Ma, J. et al. (2014) CXCL12 induces lung cancer cell migration by polarized mtDNA redistribution. Hum. Cell 27, 22-28
64. Mirisola, V. et al. (2009) CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur. J. Cancer 45, 2579-2587
65. Roy, I. et al. (2014) CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLOS ONE 9, e90400
66. Liao, Y.X. et al. (2013) The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas. Int. J. Mol. Med. 32, 1239-1246
67. Beelen, K. et al. (2014) PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy. Int. J. Cancer 135, 1257-1263
68. Campbell, D.S. and Okamoto, H. (2013) Local caspase activation interacts with Slit-Robo signaling to restrict axonal arborization. J. Cell Biol. 203, 657-672
69. Helvering, L.M. et al. (2005) Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene. Mol. Pharmacol. 68, 1225-1238
70. Macias, H. et al. (2011) SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number. Dev. Cell 20, 827-840
71. Zarubin, T. et al. (2005) Identification of eight genes that are potentially involved in tamoxifen sensitivity in breast cancer cells. Cell Res. 15, 439-446
72. Barbareschi, M. et al. (1997) Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int. J. Cancer 74, 171-174
73. Kononen, J. et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847
74. Bilir, B. et al. (2013) Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J. Transl. Med. 11, 280
75. Yang, L. et al. (2014) Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer 14, 124
76. Foldynova-Trantirkova, S. et al. (2010) Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Res. 12, R30
77. Liang, Z. et al. (2007) CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem. Biophys. Res. Commun. 359, 716-722
78. Jordan, N.J. et al. (2014) Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Res. 16, R12
79. Shah, K.N. et al. (2014) AKT-induced tamoxifen resistance is overturned by RRM2 inhibition. Mol. Cancer Res. 12, 394-407
80. Yuasa-Kawada, J. et al. (2009) Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc. Natl. Acad. Sci. U. S. A. 106, 14530-14535
81. Dickinson, R.E. et al. (2008) Novel regulated expression of the SLIT/ROBO pathway in the ovary: possible role during luteolysis in women. Endocrinology 149, 5024-5034
82. Bast, R.C., Jr et al. (2009) The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 9, 415-428
83. Dickinson, R.E. et al. (2011) Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells. PLoS ONE 6, e27792
84. Whitford, K.L. et al. (2002) Regulation of cortical dendrite development by Slit-Robo interactions. Neuron 33, 47-61
85. Dallol, A. et al. (2003) SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res. 63, 1054-1058
86. Narayan, G. et al. (2006) Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol. Cancer 5, 16
87. Tseng, R.C. et al. (2010) SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res. 70, 543-551
88. Papachristou, D.J. et al. (2012) Bone metastases: molecular mechanisms and novel therapeutic interventions. Med. Res. Rev. 32, 611-636
89. Wong, K. et al. (2001) Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 107, 209-221
90. Yiin, J.J. et al. (2009) Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol. 11, 779-789
91. Gao, L. et al. (2013) Activation of Rho GTPase Cdc42 promotes adhesion and invasion in colorectal cancer cells. Med. Sci. Monit. Basic Res. 19, 201-207
92. Yang, Y.H. et al. (2013) Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. Proc. Natl. Acad. Sci. U. S. A. 110, 16480-16485
93. Caino, M.C. et al. (2013) Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J. Clin. Invest. 123, 2907-2920
94. Shirvan, A. et al. (2002) Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J. Biol. Chem. 277, 49799-49807
95. Dong, S.M. et al. (2001) Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J. Neuropathol. Exp. Neurol. 60, 808-816